Orchestra BioMed Holdings (OBIO) Change in Acquisitions & Divestments (2023 - 2026)

Orchestra BioMed Holdings (OBIO) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 70.42% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $38.6 million (down 47.17% YoY), while the FY2025 annual figure was $49.9 million, down 42.44% from the prior year.
• Change in Acquisitions & Divestments slipped to $4.7 million in Q1 2026 per OBIO's latest filing, from $8.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $51.5 million in Q3 2023 and bottomed at $4.7 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $20.9 million across 4 years, with a median of $16.4 million in 2025.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments sank 79.39% — and 2025, when it decreased 10.42%.
• Orchestra BioMed Holdings' Change in Acquisitions & Divestments stood at $37.1 million in 2023, then sank by 53.57% to $17.2 million in 2024, then plunged by 53.85% to $8.0 million in 2025, then slumped by 40.43% to $4.7 million in 2026.
• Business Quant data shows OBIO's Change in Acquisitions & Divestments at $4.7 million in Q1 2026, $8.0 million in Q4 2025, and $9.5 million in Q3 2025.